@article{Gutiérrez Cortés_Martínez Fernández_Olaya Sanmiguel_2018, title={Sarcopenia, a new pathology that impacts old age}, volume={5}, url={https://revistaendocrino.org/index.php/rcedm/article/view/339}, DOI={10.53853/encr.5.1.339}, abstractNote={<p>Sarcopenia is a frequent syndrome in the elderly, characterized by a gradual, marked and generalized loss of skeletal muscle mass related to aging, which is evidenced in the reduction of strength and agility, which can generate physical disability which in turn increase the degree of dependence of the patient thus diminishing their quality of life and increased mortality. The European Working Group on Elderly Sarcopenia EWGSOP uses for the diagnosis of sarcopenia the presence of decreased muscle mass and deficient muscular function that is determined by the strength or performance of the patient, this diagnosis is confirmed with the criteria that they are 1. Low muscle mass, 2. Less muscle strength, 3. Less physical performance. The current management of sarcopenia employs a non-pharmacological treatment that focuses on the change of lifestyles such as increasing physical activity and improving nutrition and pharmacological treatment, which aims to recover the functionality, mobility, muscle mass of the patients. </p>}, number={1}, journal={Revista Colombiana de Endocrinología, Diabetes & Metabolismo}, author={Gutiérrez Cortés, William Arbey and Martínez Fernández, Fhara Estefanía and Olaya Sanmiguel, Laura Camila}, year={2018}, month={Mar.}, pages={28–36} }